|
Volumn 26, Issue 3, 2002, Pages 235-240
|
Primary myelodysplastic syndrome with normal cytogenetics: Utility of ‘FISH panel testing’ and M-FISH
|
Author keywords
Chromosome; Cytogenetics; FISH; Hematology; M FISH; Myelodysplastic syndrome
|
Indexed keywords
ADULT;
AGED;
ARTICLE;
CELL CYCLE;
CHROMOSOME 13Q;
CHROMOSOME ABERRATION;
CHROMOSOME DELETION 13;
CHRONIC MYELOID LEUKEMIA;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CYTOGENETICS;
DOUBLE BLIND PROCEDURE;
FEMALE;
FLUORESCENCE IN SITU HYBRIDIZATION;
HUMAN;
HUMAN TISSUE;
INTERMETHOD COMPARISON;
INTERPHASE;
KARYOTYPE;
MALE;
METAPHASE;
MYELODYSPLASTIC SYNDROME;
PRELEUKEMIA;
PRIORITY JOURNAL;
PROGNOSIS;
RANDOMIZED CONTROLLED TRIAL;
TECHNIQUE;
ANEMIA, REFRACTORY, WITH EXCESS OF BLASTS;
BONE MARROW CELLS;
CELL NUCLEUS;
CHROMOSOME DELETION;
CHROMOSOME MAPPING;
CHROMOSOMES, HUMAN, PAIR 13;
HEMATOLOGIC DISEASES;
HUMANS;
IN SITU HYBRIDIZATION, FLUORESCENCE;
INTERPHASE;
KARYOTYPING;
METAPHASE;
MONOSOMY;
MYELODYSPLASTIC SYNDROMES;
OBSERVER VARIATION;
REFERENCE VALUES;
TRISOMY;
|
EID: 17044453376
PISSN: 01452126
EISSN: None
Source Type: Journal
DOI: 10.1016/S0145-2126(01)00117-5 Document Type: Article |
Times cited : (61)
|
References (13)
|